New Drug Approval: Fda's Consideration of Evidence From Certain Clinical Trials: Report to Congressional Requesters
Creator
Unknown authorBibliographic Citation
Washington, DC: U.S. Government Accountability Office, 2010. 33 p. [Online.] Accessed: http://www.gao.gov/new.items/d10798.pdf [2011 July 14]
Permanent Link
Find in a Libraryhttp://timetravel.mementoweb.org/memento/2010/http://www.gao.gov/new.items/d10798.pdf
http://hdl.handle.net/10822/1025277
Date
2010Publisher
United States. Government Accountability Office
Collections
Metadata
Show full item recordRelated items
Showing items related by title, author, creator and subject.
-
NIH Extramural Clinical Research: Internal Controls Are Key to Safeguarding Phase III Trials Against Misconduct. Report to Congressional Requesters
Unknown author (United States. General Accounting Office [GAO], 1996-07-11)